Literature DB >> 9006721

Comparison of cationic myocardial perfusion agents: characteristics of accumulation in cultured smooth muscle cells.

K Nakamura1, T Sammiya, J Hashimoto, R Ishibashi, K Matsumoto, A Kubo.   

Abstract

The uptake and washout kinetics of two cationic lipophilic 99mTc-labeled myocardial perfusion agents, 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) 99mTc-1,2-bis[bis-2-ethoxyethyl)-phosphino]ethane (99mTc-Tetrofosmin), were studied in cultured smooth muscle cells and compared to the conventional myocardial perfusion agent, 201Tl. Both 99mTc-MIBI and 99mTc-Tetrofosmin had a 4-fold greater uptake then 201Tl, and they were washed out of cells through similar kinetics which had slower rates than 201Tl. Incubation with metabolism inhibitors had a modest influence on the uptake of these two 99mTc-labeled agents, although their extent and inhibited sites were slightly different. Ion transport inhibitors did not affect the uptake of 99mTc-MIBI, although the 99mTc-Tetrofosmin uptake was slightly inhibited when the Ca2+ channel was blocked. Our studies indicate that 99mTc-MIBI and 99mTc-Tetrofosmin were taken up by smooth muscle cells in similar pharmacokinetic patterns, but their accumulation reflected a different meaning for cell viability.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9006721     DOI: 10.1007/bf03164797

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  19 in total

1.  [Phase I clinical trial of a new myocardial imaging agent, 99mTc-PPN1011].

Authors:  A Kubo; K Nakamura; J Hashimoto; T Sammiya; S Iwanaga; S Hashimoto; Y Sasaki
Journal:  Kaku Igaku       Date:  1992-10

Review 2.  Noncardiac uptake of technetium-99m MIBI.

Authors:  C W Sutter; M J Joshi; R C Stadalnik
Journal:  Semin Nucl Med       Date:  1994-01       Impact factor: 4.446

3.  Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.

Authors:  M D Cordobes; A Starzec; L Delmon-Moingeon; C Blanchot; J C Kouyoumdjian; G Prévost; M Caglar; J L Moretti
Journal:  J Nucl Med       Date:  1996-02       Impact factor: 10.057

4.  Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocytes and subcellular localization.

Authors:  E A Platts; T L North; R D Pickett; J D Kelly
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

5.  Comparative effects of neutral dipolar compounds and lipophilic anions on technetium 99m-hexakis (2-methoxyisobutyl isonitrile) accumulation in cultured chick ventricular myocytes.

Authors:  M L Chiu; L W Herman; J F Kronauge; D Piwnica-Worms
Journal:  Invest Radiol       Date:  1992-12       Impact factor: 6.016

6.  [In vitro uptake and release of 201Tl and 99mTc-MIBI in HeLa cell].

Authors:  T Komori; R Matsui; I Adachi; T Shimizu; K Sueyoshi; I Narabayashi
Journal:  Kaku Igaku       Date:  1995-07

7.  Divergent kinetics of 201Tl and 99mTc-SESTAMIBI in cultured chick ventricular myocytes during ATP depletion.

Authors:  D Piwnica-Worms; M L Chiu; J F Kronauge
Journal:  Circulation       Date:  1992-04       Impact factor: 29.690

8.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Authors:  F J Wackers; D S Berman; J Maddahi; D D Watson; G A Beller; H W Strauss; C A Boucher; M Picard; B L Holman; R Fridrich
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

9.  Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi.

Authors:  V V Rao; M L Chiu; J F Kronauge; D Piwnica-Worms
Journal:  J Nucl Med       Date:  1994-03       Impact factor: 10.057

10.  [Phase I clinical study on 99mTc-MIBI].

Authors:  A Kubo; K Nakamura; T Sanmiya; S Shimizu; S Hashimoto; S Iwanaga; S Handa; K Torizuka
Journal:  Kaku Igaku       Date:  1991-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.